UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020925
Receipt number R000019621
Scientific Title Prevalence of chronic renal disease (CKD) in patients with rheumatoid arthritis (RA),
Date of disclosure of the study information 2016/02/08
Last modified on 2017/08/30 12:22:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prevalence of chronic renal disease (CKD) in patients with rheumatoid arthritis (RA),

Acronym

Prevalence of CKD in patients with RA,

Scientific Title

Prevalence of chronic renal disease (CKD) in patients with rheumatoid arthritis (RA),

Scientific Title:Acronym

Prevalence of CKD in patients with RA,

Region

Japan


Condition

Condition

Rheumatoid arthritis

Classification by specialty

Medicine in general Nephrology Clinical immunology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the prevalence of CKD in rheumatoid arthritis patients and the risk factors of CKD development

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Prevalence of CKD in RA patients
Risk factors associated with CKD development

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

99 years-old >

Gender

Male and Female

Key inclusion criteria

All outpatients who visited during 3 months.

Key exclusion criteria

None

Target sample size

2000


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shunsuke Mori

Organization

NHO Kumamoto Saishunsou National Hospital

Division name

Rheumatology

Zip code


Address

2659 Suya, Kohshi Japan

TEL

81-96-242-1000

Email

moris@saisyunsou1.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kokubo Katsunori

Organization

NHO Kumamoto Saishunsou National Hospital

Division name

Secretariat

Zip code


Address

2659 Suya, Kohshi Japan

TEL

81-96-242-1000

Homepage URL


Email

8211sy01@hosp.go.jp


Sponsor or person

Institute

NHO Kumamoto Saishunsou National Hospital

Institute

Department

Personal name



Funding Source

Organization

NHO Kumamoto Saishunsou National Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

熊本再春荘病院(熊本県)、佐世保中央病院(長崎県)、吉玉リウマチ科内科(鹿児島県)


Other administrative information

Date of disclosure of the study information

2016 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results

A total of 1908 patients with RA were included in this study. The prevalence of renal dysfunction based on absolute eGFR and BSA-indexed eGFR was determined. Risk factors were analyzed in multivariate logistic regression analysis.

Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Main results already published

Date of protocol fixation

2014 Year 10 Month 01 Day

Date of IRB


Anticipated trial start date

2014 Year 10 Month 02 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry

2015 Year 12 Month 31 Day

Date trial data considered complete

2015 Year 12 Month 31 Day

Date analysis concluded

2015 Year 12 Month 31 Day


Other

Other related information

Between October 2014 and May 2015, we consecutively recruited RA patients at outpatient clinics of community hospitals in Japan. Renal dysfunction was defined as an absolute estimated glomerular filtration rate (eGFR) < 60 ml/min or body surface area (BSA)-indexed eGFR < 60 ml/min/1.73 m2. Demographic and clinical characteristics were compared between patients with and without renal dysfunction. Associations between renal dysfunction and possible risk factors were examined by multivariate logistic regression analysis.


Management information

Registered date

2016 Year 02 Month 08 Day

Last modified on

2017 Year 08 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019621


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name